538 related articles for article (PubMed ID: 34357138)
21. Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death.
Martínez P; Silva M; Abarzúa S; Tevy MF; Jaimovich E; Constantine-Paton M; Bustos FJ; van Zundert B
bioRxiv; 2024 May; ():. PubMed ID: 38826246
[TBL] [Abstract][Full Text] [Related]
22. Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.
Spiller KJ; Cheung CJ; Restrepo CR; Kwong LK; Stieber AM; Trojanowski JQ; Lee VM
J Neurosci; 2016 Jul; 36(29):7707-17. PubMed ID: 27445147
[TBL] [Abstract][Full Text] [Related]
23. Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis.
Iyer AK; Jones KJ; Sanders VM; Walker CL
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473876
[TBL] [Abstract][Full Text] [Related]
24. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
[TBL] [Abstract][Full Text] [Related]
25. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
Tremblay E; Martineau É; Robitaille R
J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
[TBL] [Abstract][Full Text] [Related]
26. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease.
Moloney EB; de Winter F; Verhaagen J
Front Neurosci; 2014; 8():252. PubMed ID: 25177267
[TBL] [Abstract][Full Text] [Related]
27. Skeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALS.
Tsitkanou S; Della Gatta PA; Russell AP
Front Physiol; 2016; 7():403. PubMed ID: 27679581
[TBL] [Abstract][Full Text] [Related]
28. The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis.
Schweingruber C; Hedlund E
Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009818
[TBL] [Abstract][Full Text] [Related]
29. Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis.
Krakora D; Macrander C; Suzuki M
Neurol Res Int; 2012; 2012():379657. PubMed ID: 22919482
[TBL] [Abstract][Full Text] [Related]
30. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the
Martineau É; Arbour D; Vallée J; Robitaille R
J Neurosci; 2020 Sep; 40(40):7759-7777. PubMed ID: 32859714
[TBL] [Abstract][Full Text] [Related]
31. How to Build and to Protect the Neuromuscular Junction: The Role of the Glial Cell Line-Derived Neurotrophic Factor.
Stanga S; Boido M; Kienlen-Campard P
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374485
[TBL] [Abstract][Full Text] [Related]
32. Carboxyl-terminal modulator protein regulates Akt signaling during skeletal muscle atrophy in vitro and a mouse model of amyotrophic lateral sclerosis.
Wang J; Fry CME; Walker CL
Sci Rep; 2019 Mar; 9(1):3920. PubMed ID: 30850672
[TBL] [Abstract][Full Text] [Related]
33. Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.
Cappello V; Francolini M
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28972545
[TBL] [Abstract][Full Text] [Related]
34. Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?
Quessada C; Bouscary A; René F; Valle C; Ferri A; Ngo ST; Loeffler JP
Cells; 2021 Jun; 10(6):. PubMed ID: 34207859
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis.
Pigna E; Simonazzi E; Sanna K; Bernadzki KM; Proszynski T; Heil C; Palacios D; Adamo S; Moresi V
EBioMedicine; 2019 Feb; 40():717-732. PubMed ID: 30713114
[TBL] [Abstract][Full Text] [Related]
36. Human Motor Neurons With SOD1-G93A Mutation Generated From CRISPR/Cas9 Gene-Edited iPSCs Develop Pathological Features of Amyotrophic Lateral Sclerosis.
Kim BW; Ryu J; Jeong YE; Kim J; Martin LJ
Front Cell Neurosci; 2020; 14():604171. PubMed ID: 33328898
[TBL] [Abstract][Full Text] [Related]
37. Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death.
Ranno E; D'Antoni S; Spatuzza M; Berretta A; Laureanti F; Bonaccorso CM; Pellitteri R; Longone P; Spalloni A; Iyer AM; Aronica E; Catania MV
Neurobiol Dis; 2014 May; 65():160-71. PubMed ID: 24423643
[TBL] [Abstract][Full Text] [Related]
38. TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis.
Lépine S; Castellanos-Montiel MJ; Durcan TM
Transl Neurodegener; 2022 Dec; 11(1):56. PubMed ID: 36575535
[TBL] [Abstract][Full Text] [Related]
39. Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches.
Kubat GB; Picone P
Neurol Sci; 2024 Apr; ():. PubMed ID: 38676818
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models.
Hoye ML; Koval ED; Wegener AJ; Hyman TS; Yang C; O'Brien DR; Miller RL; Cole T; Schoch KM; Shen T; Kunikata T; Richard JP; Gutmann DH; Maragakis NJ; Kordasiewicz HB; Dougherty JD; Miller TM
J Neurosci; 2017 May; 37(22):5574-5586. PubMed ID: 28416596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]